CDKN2B and neoplasm: We used multiple open-source large datasets to identify the potential target genes regulated by CDKN2B-AS1, and also proved in vivo and in vitro that CDKN2B-AS1 affects KIRC tumor growth and metastasis, at least partly through NUF2, which can also serve as an oncogene to promot tumor progression32,33.